Kevin M. Brennan - Mar 30, 2023 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
SVP, FINANCE AND ACCOUNTING
Signature
/s/ Julia Walcott, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Mar 30, 2023
Transactions value $
$0
Form type
3
Date filed
4/3/2023, 04:07 PM
Next filing
Apr 3, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney